{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:04:05Z","timestamp":1789787045233,"version":"4.0.1"},"reference-count":46,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2002,11,24]],"date-time":"2002-11-24T00:00:00Z","timestamp":1038096000000},"content-version":"vor","delay-in-days":358,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2001,12]]},"abstract":"<jats:p><jats:bold>BACKGROUND:<\/jats:bold> CJD is usually diagnosed by clinical and neuropathological findings. A number of proteins regarded as markers for neuronal damage in plasma or serum have recently been described. Markers typical for tissue damage, although not usually associated with CJD, are another possibility. An evaluation of the relative usefulness of markers of neuronal and tissue damage in identifying CJD could be beneficial.<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:<\/jats:bold> Plasma samples were collected from 46 patients with sporadic CJD and from a control group of 42 healthy subjects. The samples were analyzed with tests that were specific for C\u2010reactive protein (CRP), IL\u20106, neuron\u2010specific enolase (NSE), S\u2010100 proteins, and cellular prion protein (PrP<jats:sup>c<\/jats:sup>). The results were compared, and a cutoff level for each test used was defined as the 90th percentile from the control group.<\/jats:p><jats:p><jats:bold>RESULTS:<\/jats:bold> The assay specific for NSE identified only 13 percent of the sporadic CJD patients as positive. The identification rate of the other markers was significantly higher: S\u2010100, 76.1 percent; PrP<jats:sup>c<\/jats:sup>, 76.1 percent; CRP, 78.3 percent; and IL\u20106, 73.3 percent. Only three of the samples were positive in all five tests.<\/jats:p><jats:p><jats:bold>CONCLUSION:<\/jats:bold> The markers for tissue damage, CRP and IL\u20106, are as useful as the previously described markers for neuronal damage in the diagnosis of CJD in plasma. All the markers tested are, however, of only limited value in the diagnosis of CJD in plasma. A combination of all surrogate markers improves the specificity but still provides no definitive diagnosis of the disease.<\/jats:p>","DOI":"10.1046\/j.1537-2995.2001.41121509.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T22:45:06Z","timestamp":1047509106000},"page":"1509-1514","source":"Crossref","is-referenced-by-count":26,"title":["C\u2010reactive protein and IL\u20106: new marker proteins for the diagnosis of CJD in plasma?"],"prefix":"10.1111","volume":"41","author":[{"given":"Dirk","family":"V\u00f6lkel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Zerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Bodemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Poser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Peter","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,11,24]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410430611"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6801762"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1675487"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(83)90168-X"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(85)90333-2"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.23.10962"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199911)46:5<774::AID-ANA14>3.0.CO;2-N"},{"key":"e_1_2_6_9_2","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJM199609263351303","article-title":"The 14\u20103\u20103 brain protein cerebrospinal fluid as a marker for transmissible spongiform encephalopathies.","volume":"335","author":"Hsich G","year":"1996","journal-title":"N Engl J Med"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1999.0732485.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410430109"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.6.811"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.4.514"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.137.6.2362"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(97)00215-2"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(92)90103-W"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2005.01.006"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004150050145"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7131.577"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1080\/02688699944195"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2001.41040441.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.59.1.103-a"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2000.17.113"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.339349"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(78)90657-1"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1984.tb05415.x"},{"key":"e_1_2_6_27_2","volume-title":"Acute phase proteins: molecular biology, biochemistry, and clinical applications","author":"Mackiewicz A","year":"1993"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.58.3.225"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3579(05)80114-1"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(88)80043-3"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(89)80476-4"},{"key":"e_1_2_6_32_2","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.4049\/jimmunol.160.11.5294","article-title":"Testosterone and IL\u20106 requirements for human C\u2010reactive protein gene expression in transgenic mice.","volume":"160","author":"Szalai AJ","year":"1998","journal-title":"J Immunol"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2990.1986.tb00045.x"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.1998.tb00175.x"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005072-199904000-00002"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.52.6.1289"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/59.10.866"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00351177"},{"key":"e_1_2_6_39_2","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.4049\/jimmunol.152.6.2995","article-title":"Sublytic complement attack exposes C\u2010reactive protein binding sites on cell membranes.","volume":"152","author":"Li YP","year":"1994","journal-title":"J Immunol"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0162-3109(99)00007-7"},{"key":"e_1_2_6_41_2","first-page":"370","article-title":"The presence of complements in amyloid plaques of Creutzfeldt\u2010Jakob disease and Gerstmann\u2010Straussler\u2010Scheinker disease.","volume":"2","author":"Ishii T","year":"1984","journal-title":"Appl Pathol"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/86562"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/86567"},{"key":"e_1_2_6_44_2","first-page":"57","article-title":"Radioimmunoassay development for human neuron\u2010specific enolase: with some clinical results in lung cancers and neuroblastoma.","volume":"6","author":"Notomi T","year":"1985","journal-title":"Tumor Biol"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365519850186562"},{"key":"e_1_2_6_46_2","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/clinchem\/38.6.813","article-title":"Age\u2010related changes of neuron\u2010specific enolase, S\u2010100 protein, and myelin basic protein concentrations in cerebrospinal fluid.","volume":"38","author":"Van Engelen BG","year":"1992","journal-title":"Clin Chem"},{"key":"e_1_2_6_47_2","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/clinchem\/44.5.1056","article-title":"Plasma S\u2010100b protein concentration in healthy adults is age\u2010 and sex\u2010independent.","volume":"44","author":"Wiesmann M","year":"1998","journal-title":"Clin Chem"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1537-2995.2001.41121509.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1537-2995.2001.41121509.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T21:06:00Z","timestamp":1697576760000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1537-2995.2001.41121509.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["10.1046\/j.1537-2995.2001.41121509.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1537-2995.2001.41121509.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}